A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings
A double-blind, placebo-controlled, parallel-group trial was performed for 4weeks, which involved continuous administration of a 1-g mesalazine suppos...
Single-stage endoscopic treatment for mild to moderate acute cholangitis associated with choledocholithiasis: a multicenter, non-randomized, open-label and exploratory clinical trial
Two-stage treatment involving stone removal after drainage is recommended for mild to moderate acute cholangitis associated with choledocholithiasis
Evaluation of formal feedback on endoscopic competence among trainees: the EFFECT trial
The study aimed to characterize the impact of feedback on colonoscopy performance among gastroenterology (GI) trainees. After feedback, caecal intubat...
Algorithm-based management of patients with gastrointestinal symptoms in patients after pelvic radiation treatment (ORBIT): a randomised controlled trial
Chronic gastrointestinal symptoms after pelvic radiotherapy are common and affect patients' quality of life. Nurse-led algorithm-based treatment was f...
A prospective, randomized assessment of a spatial orientation device in natural orifice transluminal endoscopic surgery
The Queen's NOTES group has devised a novel method of orientation by using a magnetic device that passes within an endoscope channel allowing for 3-di...
An inter-observer agreement study of autofluorescence endoscopy in Barrett's esophagus among expert and non-expert endoscopists
Autofluorescence imaging (AFI) is associated with significant false-positive results during Barrett's surveillance. The aim of this study was to asses...
Learners favour high resolution oesophageal manometry with better diagnostic accuracy over conventional line tracings
High-resolution manometry (HRM) provides a colorful representation of oesophageal motility. Novice and intermediate learners were tested to compare HR...
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience
Combination treatment with SMV and SOF in genotype 1 chronic HCV patients achieved an overall SVR rate of 78% by ITT and 86% by per protocol. The pres...